This news roundup covers several important developments in metabolic and endocrine health. GLP-1 receptor agonists after bariatric surgery amplified weight loss in a dose- and timing-dependent way. A microsimulation study found vitamin D supplementation in adults with prediabetes could cut lifetime diabetes incidence by 8%, saving over $15,000 per person. Long-term resistance training was linked to significantly lower type 2 diabetes risk in over 140,000 healthcare professionals. New investigational drugs — including oral GLP-1 agent CX11 and bofanglutide — showed promising results in early trials. HHS also proposed relaxing testosterone labeling warnings, and women with a history of premature adrenarche were found to face elevated insulin resistance risk long-term.